SAR446597
/ Sanofi
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 16, 2025
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
(clinicaltrials.gov)
- P1/2 | N=104 | Not yet recruiting | Sponsor: Sanofi
New P1/2 trial • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
October 21, 2025
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
(clinicaltrials.gov)
- P1/2 | N=104 | Recruiting | Sponsor: Sanofi | Not yet recruiting ➔ Recruiting
Enrollment open • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders
1 to 2
Of
2
Go to page
1